Integrase inhibitors reduce heart risks in people with HIV in the US

aidsmap news story

Taking an integrase inhibitor as part of an HIV treatment regimen significantly reduced the risk of a major cardiovascular event or coronary artery disease when compared to other forms of HIV treatment, a study in people with HIV in the United States has found.

The study took place in a cohort of people with HIV who may reflect the reality of HIV care in the United States – racially and ethnically diverse with a history of variable access to health care.

The study findings contradict information from studies in other parts of the world which suggest that integrase inhibitor treatment was associated with a raised risk of major cardiovascular disease.

Read the full news story here.